Company: LHI
Filing Date: 2025-11-20
Form Type: F-1/A
Source: 0001213900-25-112807
Chunk: 3

Company: Living Homeopathy International Ltd.
Filing Date: 2025-11-20
Form: F-1/A
Chunk 3
---
 B Ordinary Shares, representing
approximately 49.43% of our total voting power, assuming the underwriters do not exercise their over-allotment option. Therefore, we
do not expect that we will be a “controlled company” as defined under the Nasdaq Stock Market Rules after the completion
of this offering. Holders of Class A Ordinary Shares and Class B Ordinary Shares have the same rights except for voting and conversion
rights and restrictions on transfer of shares. Holders of Class A Ordinary Shares shall be entitled to one vote per share on all matters
subject to the vote at general meetings of our Company, and holders of Class B Ordinary Shares shall be entitled to 15 votes per share
on all matters subject to the vote at general meetings of our Company. Holders of our Class A Ordinary Shares and Class B Ordinary Shares
vote together as a single class on all matters submitted to a vote of our shareholders, except as may otherwise be required by law. Each
Class B Ordinary Share will be convertible into one Class A Ordinary Share either (i) at the option of the holder of Class B Ordinary
Shares at any time, or (ii) automatically and immediately when the holder of Class B Ordinary Shares transfers to a third party not affiliated
with such holder. Class A Ordinary Shares will not be convertible into Class B Ordinary Shares under any circumstances.

Living Homeopathy is a holding company incorporated as an exempted company on May 7, 2024 in the Cayman Islands. As a holding company with no material operations, our operations are primarily conducted by Living Homeopathy Limited (“Living Homeopathy Hong Kong” or “Living Homeopathy HK”), our wholly-owned subsidiary in Hong Kong, a special administrative region of the People’s Republic of China. This is an offering of the Class A Ordinary Shares of Living Homeopathy, the holding company incorporated in Cayman Islands, instead of shares of Living Homeopathy Hong Kong, our Hong Kong operating subsidiary. You may never directly hold any equity interest in our operating subsidiary.

We are not based in mainland
China and do not have operations or generate revenue in mainland China.We currently do not have or intend to set up any
subsidiary in mainland China, and do not foresee the need to enter into any contractual arrangements with a variable interest entity
(“VIE”) to establish a VIE structure in mainland China. For the years ended March 31, 2024 and 2025, we generated all our
revenues from Hong Kong.

Pursuant to the Basic